Claus Torp Jensen - 01 Mar 2023 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: CHIEF INNOVATION OFFICER
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol: TDOC
Transactions as of: 01 Mar 2023
Net transactions value: -$85,926
Form type: 4
Filing time: 03 Mar 2023, 15:19:26 UTC
Previous filing: 05 Dec 2022
Next filing: 07 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+11,229	+630%		13,011	01 Mar 2023	Direct	F1
transaction	TDOC	Common Stock	Sale	$85,926	-3,388	-26%	$25.36	9,623	02 Mar 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-11,229	-33%	$0.000000	22,459	01 Mar 2023	Common Stock	11,229		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3	On March 1, 2022, the reporting person was granted 33,688 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.